Date Time Anti-hyperlipidemia drug improves brain connectivity in mouse models of schizophrenia New therapies that improve connectivity and circuitry in the brain of people with schizophrenia could result from the discovery by a RIKEN-led team of a potential new target for drugs to treat the psychiatric disorder 1. Treatment for schizophrenia has not changed much in 60 years. Doctors still generally prescribe medicines designed to tame psychosis by blocking neurotransmitter signaling in the brain. While the drugs ease symptoms such as delusions and hallucinations, they leave many other aspects of the illness untreated and their side effects can be off-putting to many patients. Researchers are thus keen to find new targets for drugs.